IDiyas

For the Inventor, By the Inventor

Greensboro, NC, United States of America

Mohan Rao

USPTO Granted Patents = 11 

 

Average Co-Inventor Count = 5.5

ph-index = 4

Forward Citations = 119(Granted Patents)


Company Filing History:

goldMedal6 out of 50 
 
High Point Pharmaceuticals, LLC
 patents
silverMedal5 out of 49 
 
Transtech Pharma, Inc.
 patents

Years Active: 2008-2015

Loading Chart...
Loading Chart...
11 patents (USPTO):Explore Patents
1. 9045461 - Phenyl-heteroaryl derivatives and methods of use thereof (2015-06-02),
2. 8946259 - Benzazole derivatives, compositions, and methods of use as beta-secretase inhibitors (2015-02-03),
3. 8741900 - Phenyl-heteroaryl derivatives and methods of use thereof (2014-06-03),
4. 8718994 - Ligands for the GLP-1 receptor and methods for discovery thereof (2014-05-06),
5. 8598353 - Benzazole derivatives, compositions, and methods of use as β-secretase inhibitors (2013-12-03),
6. 8450354 - Substituted imidazo[1,2-b]pyridazine derivatives, pharmaceutical compositions, and methods of use as β-secretase inhibitors (2013-05-28),
7. 8431575 - Phenyl-heteroaryl derivatives and methods of use thereof (2013-04-30),
8. 8350039 - Substituted isoquinoline derivatives, pharmaceutical compositions, and methods of use as beta-secretase inhibitors (2013-01-08),
9. 7893267 - Benzazole derivatives, compositions, and methods of use as β-secretase inhibitors (2011-02-22),
10. 7582673 - Bissulfonamide compounds as agonists of GalR1, compositions, and methods of use (2009-09-01),
11. 7459472 - Aryl and heteroaryl compounds, compositions, and methods of use (2008-12-02),

Title: Innovator Spotlight: Mohan Rao of Greensboro, NC

Introduction

Mohan Rao is a distinguished inventor based in Greensboro, North Carolina, who holds an impressive 11 patents. His contributions to the field of pharmaceutical chemistry demonstrate a profound impact on the treatment of various diseases, particularly those mediated by the RAGE (Receptor for Advanced Glycation End Products) and BACE (β-site amyloid precursor protein-cleaving enzyme).

Latest Patents

Among his latest patents is a significant invention regarding phenyl-heteroaryl derivatives and their applications. This development provides novel compounds that are useful in treating RAGE-mediated diseases, alongside the methods for their preparation and pharmaceutical compositions. Another recent patent focuses on benzazole derivatives designed as beta-secretase inhibitors. These compounds have the potential to assist in the treatment or prevention of diseases like Alzheimer's by inhibiting the BACE enzyme.

Career Highlights

Mohan Rao has made considerable contributions while working with notable companies, including High Point Pharmaceuticals and Transtech Pharma. His innovations in the pharmaceutical sector highlight his commitment to advancing medical treatments through inventive chemistry.

Collaborations

Throughout his career, Mohan has collaborated with skilled professionals, including Robert Carl Andrews and Adnan M M Mjalli. These partnerships reflect a collaborative spirit in the pursuit of innovation and the development of effective therapeutic solutions.

Conclusion

Mohan Rao's dedication to invention and his significant patent portfolio underscore his valuable contributions to pharmaceutical sciences. His work not only paves the way for novel therapeutic options but also inspires future innovations in the field.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…